Regenera Pharma Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $16.6M
Latest Deal Amount
  • Investors
  • 4

Regenera Pharma General Information

Description

Operator of a clinical-stage pharmaceutical company intended to develop drugs and other related pharmaceutical products. The company's drugs are used to treat neurological damage caused by pathological conditions and regenerating damaged tissues, enabling patients to avail drugs for neurodegenerative diseases and chronic non-healing wounds, providing patients to restore neural function.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • 18 Einstein Street
  • Science Park
  • Ness-Ziona
  • Israel
+972 00-000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Regenera Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 02-Jan-2018 $16.6M 000.00 000.00 Completed Generating Revenue
4. Secondary Transaction - Private 00.000 Completed Generating Revenue
3. Corporate 17-Feb-2015 00.000 00.000 000.00 Completed Generating Revenue
2. Angel (individual) 01-Jan-2012 $400K $1.02M Completed Startup
1. Angel (individual) 01-Jan-2011 $625K $625K Completed Startup
To view Regenera Pharma’s complete valuation and funding history, request access »

Regenera Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred B2 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Preferred B1 000,000 00.000000 00.00 00.00 00 00.00 00.00
Preferred B 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Preferred A1 1,412,071 $0.010000 $5.75 $5.75 1x $5.75 2.78%
Preferred A 1,412,071 $0.010000 $4.6 $4.6 1x $4.6 21.24%
To view Regenera Pharma’s complete cap table history, request access »

Regenera Pharma Executive Team (7)

Name Title Board Seat Contact Info
Jordan Rubinson Chief Executive Officer
Alon Netser Chief Financial Officer
Zadik Hazan MD Co-Founder, Chief Scientific Officer & Board Member
Yoni Weiss MD Chief Medical Officer
Yitzhak Peterburg Ph.D Co-Founder & Board Member
You’re viewing 5 of 7 executive team members. Get the full list »

Regenera Pharma Board Members (5)

Name Representing Role Since
Marius Nacht aMoon Fund Chairman 000 0000
Shlomo Shalev Self Board Member 000 0000
Yair Schindel MD aMoon Fund Board Member 000 0000
Yitzhak Peterburg Ph.D Self Co-Founder & Board Member 000 0000
Zadik Hazan MD Regenera Pharma Co-Founder, Chief Scientific Officer & Board Member 000 0000
To view Regenera Pharma’s complete board members history, request access »

Regenera Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Regenera Pharma Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
aMoon Fund Venture Capital Minority 000 0000 000000 0
Angels High Tech Investments Corporation Minority 000 0000 000000 0
InterCure Corporation Minority 000 0000 000000 0
Shlomo Shalev Angel (individual) Minority 000 0000 000000 0
To view Regenera Pharma’s complete investors history, request access »